Dr. Daniel A. Hashimoto, MD, MS

Dr. Hashimoto practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Hashimoto's NPI, 1346687506, was assigned on May 29, 2013. Dr. Hashimoto graduated from Perelman School of Med at the University of Pennsylvania in 2013. Dr. Hashimoto holds Pennsylvania license MD476940.

Dr. Hashimoto's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Hashimoto's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Hashimoto is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Hashimoto to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hashimoto practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Hashimoto's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Hashimoto is licensed in Pennsylvania.

CMS data shows 93 Medicare services from Dr. Hashimoto across 6 procedure codes in 2024, for 89 Medicare patients. Medicare paid $20,333 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Hashimoto in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hashimoto's median patient age at 61, with 60% women.

In 2024, Dr. Hashimoto wrote 26 Medicare Part D claims for 13 patients. 92% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $23 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Hashimoto for performance year 2024, reported as part of a group. Dr. Hashimoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hashimoto as offering telehealth. CMS counts 15 procedures of hernia repair (minimally invasive) by Dr. Hashimoto, more than 81% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 89 papers to Dr. Hashimoto, published from 2012 to 2025. 2023 was the busiest year, with 11. The most frequent topics are Clinical Competence, Artificial Intelligence and Internship and Residency. Dr. Hashimoto has published most often in Surg Endosc. Dr. Hashimoto's most frequent co-authors are Amin Madani, MD, PhD, FRCSC, Maria Spassova Altieri, MD and Rajesh Aggarwal, MD.

CMS Open Payments shows 122 general payments to Dr. Hashimoto from 7 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 76% of the total. Medical Device Business Services, Inc. paid the most, $33,359.

Dr. Hashimoto graduated from Perelman School of Med at the University of Pennsylvania in 2013.